Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2015 FY- Text added to 2016 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
ACA, accidental, Activyl, Afferent, allogeneic, altrenogest, Aquavac, Aralez, argument, Atozet, attached, Avirulent, background, Bacterin, baterin, bench, Betamethasone, bill, Biopharma, Cabilly, carboplatin, carcinoma, CDI, CENCOEX, clarified, clarify, classical, cleaving, cloprostenol, Clotrimazole, CMS, CMV, Cogan, declaratory, degradation, DICOM, DIPRO, earliest, eDMC, element, Emamectin, entail, fenbendazole, florfenicol, flunixin, Genentech, Gentamicin, Gilead, graduated, Green, Harvoni, hepatocellular, HNSCC, Hodgkin, Hope, HTA, Hyopneumoniae, idiopathic, impracticable, inactive, India, ineligible, kind, Lancet, Lawsonia, learned, lease, legislature, Levitra, licensor, lovastatin, Magistrate, Marek, Marrow, MCM, mediastinal, meglumine, messenger, Mexico, Misuse, Moderna, Mountain, multicenter, Mycoplasma, nasopharyngeal, NAV, neurogenic, norfloxacin, Northern, Ohio, Orbifloxacin, Otic, Otomax, overturn, page, Panacur, payer, PDL, pemetrexed, porcine, pre, PRIME, PTE, qui, reallocate, recast, reconciling, refractory, relapsed, repeal, Roxane, ruzasvir, score, simplify, sofosbuvir, Solvadi, spanning, SPC, StayWell, steadily, stem, student, substitute, sulfate, suppression, tam, Tildipirosin, TPS, transparency, trenbolone, unsuccessful, untreated, uprifosbuvir, urothelial, USP, valerate, Vector, Vermont, Vestar, visit, voted, withheld, zilpaterol, zinc, Zinplava
Removed:
acid, affirming, aggressively, agree, alfa, allegedly, announce, answered, antihistamine, API, approving, Aspen, assisted, atherothrombotic, Austria, BACE, Bank, base, Basic, Becton, begun, Belgium, blockade, Brazilian, break, bulk, call, capped, CDC, certiorari, Clarinex, community, confident, Congressional, constipation, Conversely, corifollitropin, coronary, Cosopt, DEESE, density, desloratadine, devalued, Dickinson, dipeptidyl, Dodge, downplayed, Dr, economically, Eldon, elevated, enable, enactment, enhance, entirety, Eurofarma, evolution, exclusively, exhausted, failed, Fallon, feed, finalized, finasteride, fiscal, formula, Fort, Fosavance, FTC, function, Gleeson, hair, home, hormonal, incremental, induced, Inhibition, injunction, inspection, internationally, investor, ipilimumab, John, joined, lesser, lieu, Louisiana, lump, manner, minimize, Ministry, Missouri, morbidity, mortality, move, Mylan, nonforfeitable, Obama, obesity, offshore, oversaw, Parenteral, pattern, PF, Pisano, placebo, Portugal, posed, predetermined, predicting, prefilled, preladenant, presenting, prevented, prioritization, protease, rapidly, remanded, remeasurement, repricing, reproductive, retainer, retired, retroactively, revocation, rheumatoid, rocuronium, rosenblatt, routinely, Sandoz, selectively, sharpen, SICAD, similarly, Spanish, specialty, stay, stimulation, Supreme, Sweden, syringe, Taxpayer, territorial, thromboembolism, tildrakizumab, triple, Trusopt, uncured, undertaken, unrepatriated, utilize, vacated, vecuronium, venued, view, voice, voluntary, VTE, waive, WILLIE, withdrawal, withdrew, Wyeth
Valuein 2015 FY filing- Value in 2016 FY filing
Original filings
Filing view